Higuchi Hitoshi, Yabuki Akiko, Ishii-Maruhama Minako, Tomoyasu Yumiko, Maeda Shigeru, Miyawaki Takuya
Department of Dental Anesthesiology, Okayama University Hospital, Okayama, Japan.
Anesth Prog. 2014 Winter;61(4):150-4. doi: 10.2344/0003-3006-61.4.150.
Adrenaline (epinephrine) is included in dental local anesthesia for the purpose of vasoconstriction. In Japan, adrenaline is contraindicated for use in patients receiving antipsychotic therapy, because the combination of adrenaline and an antipsychotic is considered to cause severe hypotension; however, there is insufficient evidence supporting this claim. The purpose of the present study was to clarify the changes in hemodynamics caused by drug interaction between adrenaline and an antipsychotic and to evaluate the safety of the combined use of adrenaline and an antipsychotic in an animal study. Male Sprague-Dawley rats were anesthetized with sodium pentobarbital. A catheter was inserted into the femoral artery to measure blood pressure and pulse rate. Rats were pretreated by intraperitoneal injection of chlorpromazine or chlorpromazine and propranolol, and after 20 minutes, saline or 1 of 3 different doses of adrenaline was administered by intraperitoneal injection. Changes in the ratio of mean arterial blood pressure and pulse rate were measured after the injection of adrenaline. Significant hypotension and tachycardia were observed after the injection of adrenaline in the chlorpromazine-pretreated rats. These effects were in a dose-dependent manner, and 100 μg/kg adrenaline induced significant hemodynamic changes. Furthermore, in the chlorpromazine and propranolol-pretreated rats, modest hypertension was induced by adrenaline, but hypotension and tachycardia were not significantly shown. Hypotension was caused by a drug interaction between adrenaline and chlorpromazine through the activation of the β-adrenergic receptor and showed a dose-dependent effect. Low-dose adrenaline similar to what might be used in human dental treatment did not result in a significant homodynamic change.
肾上腺素被用于牙科局部麻醉以达到血管收缩的目的。在日本,肾上腺素被禁止用于接受抗精神病治疗的患者,因为肾上腺素与抗精神病药物联用被认为会导致严重低血压;然而,支持这一说法的证据并不充分。本研究的目的是在动物研究中阐明肾上腺素与抗精神病药物之间的药物相互作用所引起的血流动力学变化,并评估肾上腺素与抗精神病药物联合使用的安全性。雄性Sprague-Dawley大鼠用戊巴比妥钠麻醉。将导管插入股动脉以测量血压和脉搏率。大鼠通过腹腔注射氯丙嗪或氯丙嗪与普萘洛尔进行预处理,20分钟后,通过腹腔注射给予生理盐水或3种不同剂量的肾上腺素中的1种。注射肾上腺素后测量平均动脉血压与脉搏率的比值变化。在氯丙嗪预处理的大鼠中注射肾上腺素后观察到显著的低血压和心动过速。这些效应呈剂量依赖性,100μg/kg肾上腺素引起显著的血流动力学变化。此外,在氯丙嗪和普萘洛尔预处理的大鼠中,肾上腺素引起适度高血压,但未显著出现低血压和心动过速。低血压是由肾上腺素与氯丙嗪之间通过激活β-肾上腺素能受体的药物相互作用引起的,并呈剂量依赖性效应。类似于人类牙科治疗中使用的低剂量肾上腺素并未导致显著的血流动力学变化。